Prolonged administration of oral etoposide in patients with relapsed or refractory small-cell lung cancer: a phase II trial (Q33395941)

From Wikidata
Jump to navigation Jump to search
scientific article
edit
Language Label Description Also known as
English
Prolonged administration of oral etoposide in patients with relapsed or refractory small-cell lung cancer: a phase II trial
scientific article

    Statements

    Prolonged administration of oral etoposide in patients with relapsed or refractory small-cell lung cancer: a phase II trial (English)

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit